Stockscreener 앱 받기
12.81
4.76%
-0.64
시간 외 거래:
12.81
전일 마감가:
$13.45
열려 있는:
$13.45
하루 거래량:
23,469
Relative Volume:
0.40
시가총액:
$57.94M
수익:
-
순이익/손실:
$-24.77M
주가수익비율:
-17.55
EPS:
-0.73
순현금흐름:
$-17.36M
1주 성능:
-9.76%
1개월 성능:
-14.69%
6개월 성능:
+68.55%
1년 성능:
+75.72%
1일 변동 폭
$12.68
$13.46
1주일 범위
$12.68
$14.45
52주 변동 폭
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
명칭
Mink Therapeutics Inc
전화
212-994-8250
주소
149 FIFTH AVENUE, NEW YORK
INKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
12.81 | 60.83M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc 주식(INKT)의 최신 뉴스
Published on: 2025-11-04 04:41:21 - newser.com
Candlestick signals on MiNK Therapeutics Inc. stock todayEarnings Risk Summary & Weekly Return Optimization Plans - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock safe for risk averse investorsMarket Activity Report & Daily Oversold Bounce Ideas - newser.com
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationProfit Target & AI Based Trade Execution Alerts - newser.com
MiNK Therapeutics Inc. stock outlook for YEARAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soonAnalyst Downgrade & High Yield Stock Recommendations - newser.com
What’s next for MiNK Therapeutics Inc. stock priceMarket Rally & Long-Term Safe Investment Ideas - newser.com
Can trapped investors hope for a rebound in MiNK Therapeutics Inc.Portfolio Update Summary & Community Consensus Trade Alerts - newser.com
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
How to monitor MiNK Therapeutics Inc. with trend dashboardsJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
MiNK Therapeutics Inc. recovery potential after sell offQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilient2025 Top Decliners & AI Driven Stock Reports - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsBull Run & Fast Momentum Entry Tips - newser.com
How resilient is MiNK Therapeutics Inc. stock in market downturnsTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Can MiNK Therapeutics Inc. recover in the next quarterProduct Launch & Comprehensive Market Scan Reports - newser.com
Will MiNK Therapeutics Inc. stock benefit from sector rotationJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-11-03 01:49:46 - newser.com
Published on: 2025-11-02 23:27:12 - newser.com
Detecting price anomalies in MiNK Therapeutics Inc. with AIEarnings Miss & Weekly Breakout Stock Alerts - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockTreasury Yields & AI Powered Market Entry Strategies - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves on employment data2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Earnings Surprises & Capital Efficiency Focused Strategies - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock bottoming after sell offTrade Risk Report & Community Consensus Stock Picks - newser.com
What MACD signals say about MiNK Therapeutics Inc.Quarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-11-02 11:54:11 - newser.com
Published on: 2025-11-02 02:51:55 - newser.com
Published on: 2025-11-02 02:18:51 - newser.com
Earnings visualization tools for MiNK Therapeutics Inc.July 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Published on: 2025-11-01 08:48:26 - newser.com
How to build a custom watchlist for MiNK Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-31 04:18:27 - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-31 01:41:32 - newser.com
Mink Therapeutics Inc (INKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):